Back to search
FDAFDA · Food and drugs·Recall number D-066-2013

Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01

Published December 5, 2012 · Recall initiated: June 29, 2012

Summary

FDA records drug Class II recall D-066-2013, published December 5, 2012 and initiated June 29, 2012. Recalling firm: Mylan LLC.; Status: Terminated; Reported quantity: 15181 bottles.; Lot: Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed USP Content Uniformity Requirements: OOS result reported on retained samples.

What to do

Voluntary: Firm initiated · Letter

Get an email if TACROLIMUS has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TACROLIMUS
Manufacturer
Mylan LLC.
Distributor
Natiowide
UPC
0303782046014
Lot
Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01 recalled?

Yes. FDA published recall D-066-2013 on December 5, 2012. Reported hazard: Failed USP Content Uniformity Requirements: OOS result reported on retained samples.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0303782046014.